Literature DB >> 1918374

Deficiency of skeletal muscle succinate dehydrogenase and aconitase. Pathophysiology of exercise in a novel human muscle oxidative defect.

R G Haller1, K G Henriksson, L Jorfeldt, E Hultman, R Wibom, K Sahlin, N H Areskog, M Gunder, K Ayyad, C G Blomqvist.   

Abstract

We evaluated a 22-yr-old Swedish man with lifelong exercise intolerance marked by premature exertional muscle fatigue, dyspnea, and cardiac palpitations with superimposed episodes lasting days to weeks of increased muscle fatigability and weakness associated with painful muscle swelling and pigmenturia. Cycle exercise testing revealed low maximal oxygen uptake (12 ml/min per kg; healthy sedentary men = 39 +/- 5) with exaggerated increases in venous lactate and pyruvate in relation to oxygen uptake (VO2) but low lactate/pyruvate ratios in maximal exercise. The severe oxidative limitation was characterized by impaired muscle oxygen extraction indicated by subnormal systemic arteriovenous oxygen difference (a-v O2 diff) in maximal exercise (patient = 4.0 ml/dl, normal men = 16.7 +/- 2.1) despite normal oxygen carrying capacity and Hgb-O2 P50. In contrast maximal oxygen delivery (cardiac output, Q) was high compared to sedentary healthy men (Qmax, patient = 303 ml/min per kg, normal men 238 +/- 36) and the slope of increase in Q relative to VO2 (i.e., delta Q/delta VO2) from rest to exercise was exaggerated (delta Q/delta VO2, patient = 29, normal men = 4.7 +/- 0.6) indicating uncoupling of the normal approximately 1:1 relationship between oxygen delivery and utilization in dynamic exercise. Studies of isolated skeletal muscle mitochondria in our patient revealed markedly impaired succinate oxidation with normal glutamate oxidation implying a metabolic defect at the level of complex II of the mitochondrial respiratory chain. A defect in Complex II in skeletal muscle was confirmed by the finding of deficiency of succinate dehydrogenase as determined histochemically and biochemically. Immunoblot analysis showed low amounts of the 30-kD (iron-sulfur) and 13.5-kD proteins with near normal levels of the 70-kD protein of complex II. Deficiency of succinate dehydrogenase was associated with decreased levels of mitochondrial aconitase assessed enzymatically and immunologically whereas activities of other tricarboxylic acid cycle enzymes were increased compared to normal subjects. The exercise findings are consistent with the hypothesis that this defect impairs muscle oxidative metabolism by limiting the rate of NADH production by the tricarboxylic acid cycle.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1918374      PMCID: PMC295585          DOI: 10.1172/JCI115422

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  46 in total

1.  Kinetic determination of malate dehydrogenase activity eliminating problems due to spontaneous conversion of oxaloacetate to pyruvate.

Authors:  A R Wilcock; D M Goldberg
Journal:  Biochem Med       Date:  1972-04

2.  Biochemical studies of skeletal muscle mitochondria. I. Microanalysis of cytochrome content, oxidative and phosphorylative activities of mammalian skeletal muscle mitochondria.

Authors:  M W Makinen; C P Lee
Journal:  Arch Biochem Biophys       Date:  1968-07       Impact factor: 4.013

3.  Noninvasive determination of cardiac output by a modified acetylene rebreathing procedure utilizing mass spectrometer measurements.

Authors:  J H Triebwasser; R L Johnson; R P Burpo; J C Campbell; W C Reardon; C G Blomqvist
Journal:  Aviat Space Environ Med       Date:  1977-03

4.  Measurement of cytochromes in human skeletal muscle mitochondria, isolated from fresh and frozen stored muscle specimens.

Authors:  H Bookelman; J M Trijbels; R C Sengers; A J Janssen
Journal:  Biochem Med       Date:  1978-06

5.  Effects of dietary iron deficiency of iron-sulfur proteins and bioenergetic functions of skeletal muscle mitochondria.

Authors:  J J Maguire; K J Davies; P R Dallman; L Packer
Journal:  Biochim Biophys Acta       Date:  1982-02-17

6.  Mitochondrial myopathy. Biochemical studies revealing a deficiency of NADH--cytochrome b reductase activity.

Authors:  J M Land; J A Morgan-Hughes; J B Clark
Journal:  J Neurol Sci       Date:  1981-04       Impact factor: 3.181

7.  Defective oxidative metabolism of myodystrophic skeletal muscle mitochondria.

Authors:  C P Lee; M E Martens; L Jankulovska; M A Neymark
Journal:  Muscle Nerve       Date:  1979 Sep-Oct       Impact factor: 3.217

8.  A mitochondrial myopathy characterized by a deficiency in reducible cytochrome b.

Authors:  J A Morgan-Hughes; P Darveniza; S N Kahn; D N Landon; R M Sherratt; J M Land; J B Clark
Journal:  Brain       Date:  1977-12       Impact factor: 13.501

9.  Substrate activity of structural analogs of isocitrate for isocitrate dehydrogenases from bovine heart.

Authors:  G W Plaut; R L Beach; T Aogaichi
Journal:  Biochemistry       Date:  1975-06-17       Impact factor: 3.162

10.  Mechanisms regulating the cardiac output response to cyanide infusion, a model of hypoxia.

Authors:  C Liang; W E Huckabee
Journal:  J Clin Invest       Date:  1973-12       Impact factor: 14.808

View more
  33 in total

1.  Short-term exercise training improves the cardiovascular response to exercise in the postural orthostatic tachycardia syndrome.

Authors:  Shigeki Shibata; Qi Fu; Tiffany B Bivens; Jeffrey L Hastings; Wade Wang; Benjamin D Levine
Journal:  J Physiol       Date:  2012-05-28       Impact factor: 5.182

Review 2.  Metabolic Myoglobinuria.

Authors:  Emanuele Barca; Valentina Emmanuele; Salvatore Billi DiMauro
Journal:  Curr Neurol Neurosci Rep       Date:  2015-10       Impact factor: 5.081

Review 3.  Single-gene disorders: what role could moonlighting enzymes play?

Authors:  Ganesh Sriram; Julian A Martinez; Edward R B McCabe; James C Liao; Katrina M Dipple
Journal:  Am J Hum Genet       Date:  2005-04-22       Impact factor: 11.025

Review 4.  .VO2max: what do we know, and what do we still need to know?

Authors:  Benjamin D Levine
Journal:  J Physiol       Date:  2007-11-15       Impact factor: 5.182

Review 5.  The clinical maze of mitochondrial neurology.

Authors:  Salvatore DiMauro; Eric A Schon; Valerio Carelli; Michio Hirano
Journal:  Nat Rev Neurol       Date:  2013-07-09       Impact factor: 42.937

6.  Exertional dyspnea in mitochondrial myopathy: clinical features and physiological mechanisms.

Authors:  Katja Heinicke; Tanja Taivassalo; Phil Wyrick; Helen Wood; Tony G Babb; Ronald G Haller
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-03       Impact factor: 3.619

7.  Tissue specificity of a human mitochondrial disease: differentiation-enhanced mis-splicing of the Fe-S scaffold gene ISCU renders patient cells more sensitive to oxidative stress in ISCU myopathy.

Authors:  Daniel R Crooks; Suh Young Jeong; Wing-Hang Tong; Manik C Ghosh; Hayden Olivierre; Ronald G Haller; Tracey A Rouault
Journal:  J Biol Chem       Date:  2012-10-03       Impact factor: 5.157

8.  Deleterious mutation in FDX1L gene is associated with a novel mitochondrial muscle myopathy.

Authors:  Ronen Spiegel; Ann Saada; Jonatan Halvardson; Devorah Soiferman; Avraham Shaag; Simon Edvardson; Yoseph Horovitz; Morad Khayat; Stavit A Shalev; Lars Feuk; Orly Elpeleg
Journal:  Eur J Hum Genet       Date:  2013-11-27       Impact factor: 4.246

Review 9.  Exercise in the postural orthostatic tachycardia syndrome.

Authors:  Qi Fu; Benjamin D Levine
Journal:  Auton Neurosci       Date:  2014-11-21       Impact factor: 3.145

10.  Conditional knockout of Mn-SOD targeted to type IIB skeletal muscle fibers increases oxidative stress and is sufficient to alter aerobic exercise capacity.

Authors:  Michael S Lustgarten; Youngmok C Jang; Yuhong Liu; Florian L Muller; Wenbo Qi; Mark Steinhelper; Susan V Brooks; Lisa Larkin; Takahiko Shimizu; Takuji Shirasawa; Linda M McManus; Arunabh Bhattacharya; Arlan Richardson; Holly Van Remmen
Journal:  Am J Physiol Cell Physiol       Date:  2009-09-23       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.